DRUG

imatinib

2 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for imatinib

Epilepsy 1

Mediator Outcome Score Tier Lit. status Trial
CSF1R seizure 0.269 Mid partial evidence none

Multiple sclerosis 1

Mediator Outcome Score Tier Lit. status Trial
CSF1R neurological impairments 0.269 Mid partial evidence none

Clinical trials

200 registered trials for imatinib

Source: ClinicalTrials.gov